BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22327953)

  • 1. [Perioperative management of antiplatelet therapy in thoracic surgery. A survey of German hospitals].
    Wiesemann S; Passlick B
    Chirurg; 2012 Jun; 83(6):576-82. PubMed ID: 22327953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
    Xia JG; Qu Y; Shen H; Liu XH
    Coron Artery Dis; 2013 Sep; 24(6):522-6. PubMed ID: 23900046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual antiplatelet therapy with aspirin and clopidogrel: what is the risk in noncardiac surgery? A narrative review.
    Finkel JB; Marhefka GD; Weitz HH
    Hosp Pract (1995); 2013 Feb; 41(1):79-88. PubMed ID: 23466970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant differences between vascular and nonvascular surgeons in the perioperative management of antiplatelet therapies in patients with coronary stents.
    Kilic A; Sultan IS; Arnaoutakis GJ; Black JH; Reifsnyder T
    Ann Vasc Surg; 2015 Apr; 29(3):526-33.e2. PubMed ID: 25476748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic laparoscopy under dual antiplatelet therapy with clopidogrel and aspirin].
    Vogt A; Schlitt A; Buerke M; Mannes F; Wolf HH; Werdan K; Plehn A
    Med Klin Intensivmed Notfmed; 2011 Sep; 106(1):48-51. PubMed ID: 21975842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery.
    Stone DH; Goodney PP; Schanzer A; Nolan BW; Adams JE; Powell RJ; Walsh DB; Cronenwett JL;
    J Vasc Surg; 2011 Sep; 54(3):779-84. PubMed ID: 21571492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ASA and clopidogrel for urological operations. Perioperative management].
    Fischer C; Lümmen G
    Urologe A; 2013 Nov; 52(11):1597-605. PubMed ID: 24121474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.
    Faxon DP; Lawler E; Young M; Gaziano M; Kinlay S
    Circ Cardiovasc Interv; 2012 Jun; 5(3):372-80. PubMed ID: 22668555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome.
    Jiang M; You JHS
    Clin Cardiol; 2017 Oct; 40(10):789-796. PubMed ID: 28683175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).
    Didier R; Morice MC; Barragan P; Noryani AAL; Noor HA; Majwal T; Hovasse T; Castellant P; Schneeberger M; Maillard L; Bressolette E; Wojcik J; Delarche N; Blanchard D; Jouve B; Ormezzano O; Paganelli F; Levy G; Sainsous J; Carrie D; Furber A; Berlan J; Darremont O; Le Breton H; Lyuycx-Bore A; Gommeaux A; Cassat C; Kermarrec A; Cazaux P; Druelles P; Dauphin R; Armengaud J; Dupouy P; Champagnac D; Ohlmann P; Ben Amer H; Kiss RG; Ungi I; Gilard M
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1202-1210. PubMed ID: 28641840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
    Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
    JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel dilemma for orthopaedic surgeons.
    Steele MJ; Fox JS; Fletcher JP; Grigg LE; Bell G
    ANZ J Surg; 2011 Nov; 81(11):774-84. PubMed ID: 22295376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
    Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
    JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation.
    Nakamura M; Iijima R; Ako J; Shinke T; Okada H; Ito Y; Ando K; Anzai H; Tanaka H; Ueda Y; Takiuchi S; Nishida Y; Ohira H; Kawaguchi K; Kadotani M; Niinuma H; Omiya K; Morita T; Zen K; Yasaka Y; Inoue K; Ishiwata S; Ochiai M; Hamasaki T; Yokoi H;
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1189-1198. PubMed ID: 28641838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy in the perioperative period.
    Václavík J; Táborský M
    Eur J Intern Med; 2011 Feb; 22(1):26-31. PubMed ID: 21238889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures.
    Allemang MT; Rajani RR; Nelson PR; Hingorani A; Kashyap VS
    Ann Vasc Surg; 2013 Jan; 27(1):62-7. PubMed ID: 22981017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal variability in the antiplatelet effects of clopidogrel and aspirin after elective drug-eluting stent implantation. An ADAPT-DES substudy.
    Nührenberg TG; Stratz C; Leggewie S; Hochholzer W; Valina CM; Gick M; Kirtane AJ; Stone GW; Neumann FJ; Trenk D
    Thromb Haemost; 2015 Nov; 114(5):1020-7. PubMed ID: 26305340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy.
    Kulik A; Chan V; Ruel M
    Expert Opin Drug Saf; 2009 Mar; 8(2):169-82. PubMed ID: 19309245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents: the DATE (Duration of Dual Antiplatelet Therapy AfterImplantation of Endeavor Stent) registry.
    Hahn JY; Song YB; Choi JH; Choi SH; Lee SY; Park HS; Hur SH; Lee S; Han KR; Rha SW; Cho BR; Park JS; Yoon J; Lim DS; Lee SH; Gwon HC;
    Circ J; 2010 Nov; 74(11):2314-21. PubMed ID: 20938098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
    Mauri L; Kereiakes DJ; Yeh RW; Driscoll-Shempp P; Cutlip DE; Steg PG; Normand SL; Braunwald E; Wiviott SD; Cohen DJ; Holmes DR; Krucoff MW; Hermiller J; Dauerman HL; Simon DI; Kandzari DE; Garratt KN; Lee DP; Pow TK; Ver Lee P; Rinaldi MJ; Massaro JM;
    N Engl J Med; 2014 Dec; 371(23):2155-66. PubMed ID: 25399658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.